<DOC>
	<DOCNO>NCT00919893</DOCNO>
	<brief_summary>In placebo control study safety efficacy Cernilton , standardize pollen extract , men inflammatory chronic prostatitis-chronic pelvic pain syndrome investigate . The purpose study determine whether Cernilton safe effective patient inflammatory chronic prostatitis-chronic pelvic pain syndrome .</brief_summary>
	<brief_title>Efficacy Study Standardized Pollen Extract Preparation ( Cernilton ) Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome ( CP-CPPS )</brief_title>
	<detailed_description>We conduct multicenter , randomize , double-blind , placebo-controlled trial ass safety efficacy Cernilton , standardize pollen extract , men inflammatory CP-CPPS ( National Institutes Health ( NIH ) type IIIA ) . Participants randomize Cernilton placebo 12 week evaluate use National Institutes Health Chronic Prostatitis Symptom Index ( NIH-CPSI ) individual domains total score , number leukocyte post prostatic massage urine , International Prostate Symptom Score ( IPSS ) sexuality domain life satisfaction questionnaire baseline 6 12 week .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Prostatitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>men 18 65 year symptoms pelvic pain least 3 month 6 month study entry score pain domain German validate version NIH chronic prostatitis symptom index ( NIHCPSI ) 7 high leukocyte 10 post prostate massage urine urinary tract infection acute bacterial chronic bacterial prostatitis history urethritis discharge 4 week prior study entry history epididymitis sexually transmit disease residual urine volume 50 mL due bladder outlet obstruction indication history prostate surgery include prostate biopsy treatment phytotherapeutic agent alphablocker agent antimicrobial substance prostatic penetration 4 week prior study entry treatment agent influence intraprostatic hormone metabolism 6 month prior study entry</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>chronic prostatitis symptom index</keyword>
	<keyword>male</keyword>
	<keyword>inflammatory</keyword>
	<keyword>CP-CPPS</keyword>
	<keyword>Cernilton</keyword>
	<keyword>pelvic pain</keyword>
	<keyword>symptom</keyword>
</DOC>